Topiramate 10370-0365
Product NDC
10370-0365- Manufacturer
- Endo Usa, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 24, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA205976
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 25 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(2)
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-01)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10370-365-11)